PE20020433A1 - Compuestos heterociclicos como agentes anticolinergicos - Google Patents
Compuestos heterociclicos como agentes anticolinergicosInfo
- Publication number
- PE20020433A1 PE20020433A1 PE2001001018A PE2001001018A PE20020433A1 PE 20020433 A1 PE20020433 A1 PE 20020433A1 PE 2001001018 A PE2001001018 A PE 2001001018A PE 2001001018 A PE2001001018 A PE 2001001018A PE 20020433 A1 PE20020433 A1 PE 20020433A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- metobromide
- diphenyl
- halogen
- ester
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 title abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000002148 esters Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- NMGODFWGUBLTTA-UHFFFAOYSA-N 3-amino-1h-quinazoline-2,4-dione Chemical compound C1=CC=C2C(=O)N(N)C(=O)NC2=C1 NMGODFWGUBLTTA-UHFFFAOYSA-N 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 2
- MAGCRYYXZYUDSY-UHFFFAOYSA-N 2-fluoro-2,2-diphenylacetic acid Chemical compound C=1C=CC=CC=1C(F)(C(=O)O)C1=CC=CC=C1 MAGCRYYXZYUDSY-UHFFFAOYSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE A ES -CH2-CH2-, -CH=CH-, ENTRE OTROS; X- ES UN ANION CON CARGA NEGATIVA SIMPLE; R1 Y R2 SON ALQUILO C1-C4 SUSTITUIDOS CON HIDROXI, HALOGENO; R3, R4, R5, R6 SON H, ALQUILO C1-C4-OXI, HIDROXI, CF3, CH, NO2, HALOGENO; R7 ES H, ALQUILO C1-C4, ALQUIL C1-C4-OXI, ALQUILEN C1-C4-HALOGENO, HALOGENO-ALQUIL C1-C4-OXI, ENTRE OTROS. EN EL CASO QUE A REPRESENTE -CH2-CH2- R1 Y R2 SON METILO; R3, R4, R5, R6 SON H Y R7 NO PUEDE SER H. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS. SON COMPUESTROS PREFERIDOS METOBROMURO DEL ESTER DE TROPENOL CON ACIDO 2,2-DIFENIL-PROPIONICO, METOBROMURO DEL ESTER DE ESCOPINA CON ACIDO 2,2-DIFENIL-PROPIONICO, METOBROMURO DEL ESTER DE ESCOPINA CON ACIDO 2-FLUORO-2,2-DIFENIL-ACETICO, METOBROMURO DEL ESTER DE TROPENOL CON ACIDO 2-FLUORO-2,2-DIFENIL-ACETICO. LOS COMPUESTOS MENCIONADOS SON AGENTES ANTICOLINERGICOS UTILES EN EL TRATAMIENTO DE ASMA, ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10050994A DE10050994A1 (de) | 2000-10-14 | 2000-10-14 | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020433A1 true PE20020433A1 (es) | 2002-06-28 |
Family
ID=7659808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001001018A PE20020433A1 (es) | 2000-10-14 | 2001-10-12 | Compuestos heterociclicos como agentes anticolinergicos |
Country Status (37)
| Country | Link |
|---|---|
| EP (2) | EP1382606A3 (es) |
| JP (2) | JP4109106B2 (es) |
| KR (1) | KR100830359B1 (es) |
| CN (1) | CN1275962C (es) |
| AR (1) | AR035589A1 (es) |
| AT (1) | ATE259805T1 (es) |
| AU (2) | AU1397502A (es) |
| BG (1) | BG66225B1 (es) |
| BR (1) | BR0114635A (es) |
| CA (1) | CA2425557C (es) |
| DE (2) | DE10050994A1 (es) |
| DK (1) | DK1325001T3 (es) |
| EA (1) | EA005816B1 (es) |
| EC (1) | ECSP034542A (es) |
| EE (1) | EE05179B1 (es) |
| ES (1) | ES2215147T3 (es) |
| HR (1) | HRP20030278B1 (es) |
| HU (1) | HUP0301203A3 (es) |
| IL (2) | IL155334A0 (es) |
| ME (1) | MEP39908A (es) |
| MX (1) | MXPA03003160A (es) |
| MY (1) | MY127144A (es) |
| NO (1) | NO328207B1 (es) |
| NZ (1) | NZ525836A (es) |
| PE (1) | PE20020433A1 (es) |
| PL (1) | PL207311B1 (es) |
| PT (1) | PT1325001E (es) |
| RS (1) | RS50464B (es) |
| SA (1) | SA01220414B1 (es) |
| SI (1) | SI1325001T1 (es) |
| SK (1) | SK287138B6 (es) |
| TR (1) | TR200400376T4 (es) |
| TW (1) | TWI306098B (es) |
| UA (1) | UA73804C2 (es) |
| UY (1) | UY26958A1 (es) |
| WO (1) | WO2002032899A1 (es) |
| ZA (1) | ZA200302914B (es) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10200943A1 (de) | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| DE10203753A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| US7405224B2 (en) | 2002-01-31 | 2008-07-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions |
| ES2248767T3 (es) * | 2002-04-12 | 2006-03-16 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Medicamento que contiene beta-mimeticos y un nuevo anticolinergico. |
| DE10256317A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum |
| US7417051B2 (en) | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
| US7084153B2 (en) | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
| DE10216429A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittel enthaltend Steroide und ein neues Anticholinergikum |
| DE10224091A1 (de) * | 2002-05-31 | 2003-12-11 | Boehringer Ingelheim Pharma | Technisches Verfahren zur Herstellung von Tropenol |
| DE10230750A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten |
| DE10230751A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern |
| DE60310730T2 (de) * | 2002-07-09 | 2007-05-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
| DE10230769A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren |
| RS51396B (sr) * | 2002-08-14 | 2011-02-28 | Boehringer Ingelheim Pharma Gmbh & Co.Kg. | Aerosolna formulacija za inhaliranje koja sadrži antiholinergik |
| DE10237739A1 (de) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
| US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| DE10317461A1 (de) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
| US7332175B2 (en) | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
| DE10323966A1 (de) * | 2003-05-27 | 2004-12-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen |
| DE10331350A1 (de) * | 2003-07-11 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum |
| US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
| US7273603B2 (en) | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
| CA2533786A1 (en) * | 2003-07-28 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
| ATE435018T1 (de) * | 2003-07-28 | 2009-07-15 | Boehringer Ingelheim Int | Medikamente zur inhalation mit steroiden und einem neuen fluorencarbonsäureester |
| CA2533791C (en) * | 2003-07-28 | 2012-05-22 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| PT1651270E (pt) * | 2003-07-29 | 2007-04-30 | Boehringer Ingelheim Int | Medicamentos para inalação compreendendo betamiméticos e um anticolinérgico |
| CA2534120C (en) * | 2003-07-31 | 2012-09-11 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising anticholinergics and a betamimetic |
| EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| DE10345065A1 (de) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| CA2547394A1 (en) * | 2004-01-09 | 2005-07-28 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| JP2007523116A (ja) * | 2004-02-20 | 2007-08-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗コリン作用薬及びｐｅｇｓｕｎｅｒｃｅｐｔを基にした新規な医薬組成物 |
| US20050186175A1 (en) * | 2004-02-20 | 2005-08-25 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins |
| US7507745B2 (en) | 2004-02-20 | 2009-03-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
| DE102004016179A1 (de) * | 2004-03-30 | 2005-10-20 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von proliferativen Prozessen |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| ES2322148T3 (es) * | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
| DE102004056578A1 (de) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid |
| EP1855689A1 (en) * | 2005-02-16 | 2007-11-21 | Boehringer Ingelheim International GmbH | Pharmaceutical compositions comprising anticholinergics and etiprednol |
| WO2006094924A2 (en) * | 2005-03-09 | 2006-09-14 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| EP1893203A2 (en) * | 2005-05-31 | 2008-03-05 | Boehringer Ingelheim International GmbH | Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| CA2611907A1 (en) * | 2005-06-17 | 2006-12-21 | Boehringer Ingelheim International Gmbh | Mrp iv inhibitors for the treatment of respiratory diseases |
| DE102005030733A1 (de) | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff |
| CN101208316B (zh) | 2005-08-15 | 2012-05-09 | 贝林格尔·英格海姆国际有限公司 | 制备β-模拟物的方法 |
| WO2007045979A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| DE102005055963A1 (de) * | 2005-11-24 | 2007-07-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| DE102005055961A1 (de) * | 2005-11-24 | 2007-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| DE102005055957A1 (de) * | 2005-11-24 | 2007-07-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| ES2360963T3 (es) | 2006-08-07 | 2011-06-10 | Boehringer Ingelheim International Gmbh | Combinaciones de fármacos para el tratamiento de enfermedades de las vías respiratorias. |
| US20080207659A1 (en) | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| EP2124944B1 (en) | 2007-03-14 | 2012-02-15 | Ranbaxy Laboratories Limited | Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors |
| ES2569359T3 (es) | 2007-07-06 | 2016-05-10 | Vectura Delivery Devices Limited | Inhalador |
| WO2009010492A2 (en) * | 2007-07-18 | 2009-01-22 | Boehringer Ingelheim International Gmbh | Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| EP2082771A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082766A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Blister Strip Coil Forming |
| EP2082768A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082767A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082772A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| US9265910B2 (en) | 2009-05-18 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Adapter, inhalation device, and nebulizer |
| GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| AP3141A (en) | 2009-11-25 | 2015-02-28 | Boehringer Ingelheim Int | Nebulizer |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| AU2013360691B2 (en) | 2012-12-21 | 2018-03-08 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
| LT3473255T (lt) | 2012-12-21 | 2022-03-10 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė vaisto forma, apimanti ciklezonidą |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
| EP3139984B1 (en) | 2014-05-07 | 2021-04-28 | Boehringer Ingelheim International GmbH | Nebulizer |
| DK3139979T3 (da) | 2014-05-07 | 2023-10-09 | Boehringer Ingelheim Int | Enhed, forstøver og fremgangsmåde |
| CN106456913B (zh) | 2014-05-07 | 2019-08-30 | 勃林格殷格翰国际有限公司 | 喷雾器和容器 |
| PL3157522T3 (pl) | 2014-06-18 | 2020-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Antagonisty muskarynowi i ich kombinacje do leczenia choroby dróg oddechowych u koni |
| JP6868008B2 (ja) * | 2015-09-04 | 2021-05-12 | ヤンセン ファーマシューティカ エヌ．ベー． | 疼痛のための治療化合物及びその合成 |
| CN113292574B (zh) * | 2020-02-21 | 2022-05-03 | 四川大学 | 一类手性多环的托品烷化合物及其制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4003270A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgase und ihre verwendung in arzneimittelzubereitungen |
| DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
-
2000
- 2000-10-14 DE DE10050994A patent/DE10050994A1/de not_active Withdrawn
-
2001
- 2001-09-28 UA UA2003054186A patent/UA73804C2/uk unknown
- 2001-09-28 KR KR1020037005256A patent/KR100830359B1/ko not_active Expired - Fee Related
- 2001-09-28 IL IL15533401A patent/IL155334A0/xx active IP Right Grant
- 2001-09-28 TR TR2004/00376T patent/TR200400376T4/xx unknown
- 2001-09-28 PT PT01982374T patent/PT1325001E/pt unknown
- 2001-09-28 WO PCT/EP2001/011226 patent/WO2002032899A1/de not_active Ceased
- 2001-09-28 NZ NZ525836A patent/NZ525836A/en not_active IP Right Cessation
- 2001-09-28 CN CNB018171443A patent/CN1275962C/zh not_active Expired - Lifetime
- 2001-09-28 BR BR0114635-1A patent/BR0114635A/pt not_active IP Right Cessation
- 2001-09-28 SK SK435-2003A patent/SK287138B6/sk not_active IP Right Cessation
- 2001-09-28 PL PL360673A patent/PL207311B1/pl not_active IP Right Cessation
- 2001-09-28 DK DK01982374T patent/DK1325001T3/da active
- 2001-09-28 HU HU0301203A patent/HUP0301203A3/hu unknown
- 2001-09-28 RS YUP-295/03A patent/RS50464B/sr unknown
- 2001-09-28 EP EP03023933A patent/EP1382606A3/de not_active Withdrawn
- 2001-09-28 AU AU1397502A patent/AU1397502A/xx active Pending
- 2001-09-28 HR HR20030278A patent/HRP20030278B1/xx not_active IP Right Cessation
- 2001-09-28 DE DE50101524T patent/DE50101524D1/de not_active Expired - Lifetime
- 2001-09-28 EA EA200300459A patent/EA005816B1/ru not_active IP Right Cessation
- 2001-09-28 ME MEP-399/08A patent/MEP39908A/xx unknown
- 2001-09-28 AT AT01982374T patent/ATE259805T1/de active
- 2001-09-28 JP JP2002536281A patent/JP4109106B2/ja not_active Expired - Lifetime
- 2001-09-28 MX MXPA03003160A patent/MXPA03003160A/es active IP Right Grant
- 2001-09-28 SI SI200130085T patent/SI1325001T1/xx unknown
- 2001-09-28 AU AU2002213975A patent/AU2002213975B2/en not_active Expired
- 2001-09-28 EP EP01982374A patent/EP1325001B1/de not_active Expired - Lifetime
- 2001-09-28 CA CA002425557A patent/CA2425557C/en not_active Expired - Lifetime
- 2001-09-28 EE EEP200300151A patent/EE05179B1/xx not_active IP Right Cessation
- 2001-09-28 ES ES01982374T patent/ES2215147T3/es not_active Expired - Lifetime
- 2001-10-02 SA SA01220414A patent/SA01220414B1/ar unknown
- 2001-10-10 UY UY26958A patent/UY26958A1/es not_active Application Discontinuation
- 2001-10-12 PE PE2001001018A patent/PE20020433A1/es not_active Application Discontinuation
- 2001-10-12 TW TW090125220A patent/TWI306098B/zh not_active IP Right Cessation
- 2001-10-12 AR ARP010104785A patent/AR035589A1/es active IP Right Grant
- 2001-10-12 MY MYPI20014765A patent/MY127144A/en unknown
-
2003
- 2003-03-28 BG BG107688A patent/BG66225B1/bg unknown
- 2003-04-07 EC EC2003004542A patent/ECSP034542A/es unknown
- 2003-04-10 IL IL155334A patent/IL155334A/en not_active IP Right Cessation
- 2003-04-11 ZA ZA200302914A patent/ZA200302914B/en unknown
- 2003-04-11 NO NO20031693A patent/NO328207B1/no not_active IP Right Cessation
-
2008
- 2008-02-14 JP JP2008033492A patent/JP2008120834A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020433A1 (es) | Compuestos heterociclicos como agentes anticolinergicos | |
| PE20020721A1 (es) | Derivados de quinuclidina como agentes antimuscarinicos m3 | |
| DK0647227T3 (da) | Purinon antianginamidler | |
| ES8103015A1 (es) | Procedimiento para preparar derivados de polioles | |
| IE791004L (en) | 1-phenyl-2-aminoethanol derivatives | |
| SE7702609L (sv) | Aminoalkylheterocykler | |
| TR199902303T2 (xx) | Belirli halkal� tiyo ornat�lm�� a�ilaminoasit amit t�revleri. | |
| FI884132A0 (fi) | 1-/ (2-pyrimidinyl) -aminoalkyl/-piperidiner, deras framstaellning och anvaendning i terapi. | |
| NO924949D0 (no) | Piperidylsubstituerte indoler | |
| ES2112421T3 (es) | Nuevos farmacos a base de fosfolipidos acilados. | |
| AR063894A1 (es) | Uso de un acido indazolmetoxialcanoico para preparar una composicion farmaceutica | |
| NO830843L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7-substituerte theofyllindervater | |
| NO942757L (no) | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater | |
| GB2108495B (en) | Triazoloquinazolone derivatives | |
| FI842966A0 (fi) | Triazolo-pyrimidinderivat, foerfarande foer deras framstaellning samt deras terapeutiska anvaendning som hjaertmediciner. | |
| ES454086A1 (es) | Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-norosimorfona nuevas. | |
| ATE88467T1 (de) | Pharmakologisch aktive alkylol-derivate. | |
| EP1056700A4 (en) | MEDICAL APPLICATIONS OF PHENYL ALCOHOLS AND DERIVATIVES THEREOF | |
| FI883483A0 (fi) | Piperidinderivat, deras framstaellning och anvaendning vid terapi. | |
| SE8204393L (sv) | Nya bicykliska foreningar jemte sett for deras framstellning | |
| SE8007193L (sv) | Nya pyridiner och pyrimidiner med antiinflammatorisk och immunoregulatorisk verkan | |
| DK190086A (da) | Carboxylsyreestere, deres fremstilling og anvendelse som insecticider, samt ved fremstillingen anvendelige mellemprodukter | |
| GB1025698A (en) | Improvements in or relating to 5,6-dihydromorphanthridine derivatives | |
| DE69632078D1 (de) | 3-aminopropoxyphenyl-derivate | |
| ES8201163A1 (es) | Un procedimiento para la preparacion de derivados de imida- zodiacepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |